Clinical Trial Update: Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study evaluating nitazoxanide-based regimens to treat Helicobacter pylori-associated gastritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis
• Helicobacter Pylori Infection

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Helicobacter-associated Gastritis | Phase 3 | Status: UNKNOWN